Shots:

• The clinical study involves assessing HeadaTerm TENS therapy in patients that were divided into two groups: a sham group & a verum group- both the groups underwent therapy for 20mins
• The clinical study results: change in VAS from 0 to 120mins (-65.46 ± 25.11 & -9.46 ± 2.61); verbal score @120mins. (1.2 & 4.5); analgesic requirement after 120mins (76.92% & 2%); HeadaTerm TENS device demonstrated 11.8% better rate in decreasing pain than acute migraine medications
• HeadaTerm is a wearable anti-migraine device that utilizes electrical stimulation to target CNS’pain receptors by releasing pain-countering neurotransmitters. HeadaTerm’s TENS therapy is the fast-acting and effective treatment of acute migraine

Click here ­to­ read full press release/ article | Ref: WAT Medical | Image: Wat Medical